Augmentation of fluoxetine with lovastatin for treating major depressive disorder, a randomized double-blind placebo controlled-clinical trial.

A, Ghanizadeh; A, Hedayati

doi:10.1002/da.22195

Public

Augmentation of fluoxetine with lovastatin for treating major depressive disorder, a randomized double-blind placebo controlled-clinical trial.

Published in Depression and anxiety • Sep 30, 2013

Authors:

Ghanizadeh A

Hedayati A

Abstract

<h4>Backgrounds</h4>There are contradictory evidence about the effect of statins on depression. This 6-week-randomized placebo-controlled clinical trial assessed the efficacy and safety of lovastatin as an adjuvant agent for treating major depressive disorder (MDD).<h4>Methods</h4>The participants w...

View

Paywalled

View Full Text

Subject

Treatment

Statin

Major Depressive Disorder

Generate AI Take for this paper

Highlights, strengths & weaknesses, commercial applications, and societal impact — written for this paper on demand.

Subject

Generate AI Take for this paper

Discussions